Edinburgh Pain Assessment Tool (EPAT©) Study

NACompletedINTERVENTIONAL
Enrollment

1,928

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Cancer
Interventions
BEHAVIORAL

EPAT© Educational Package

The EPAT package consists of an education programme, which deals with the known common barriers to effective pain control and the bedside pain tool. The pain tool is uniquely incorporated into the vital signs chart to enable a systematic approach to cancer pain assessment and review. EPAT consists of 2 steps: step 1 is a colour-coded pain assessment on the bedside vital signs chart. Patients with moderate or severe pain on step 1 will progress to to step 2, which helps to identify the aetiology of the pain, screening for opioid side effects and is linked via flags to simple management plans. The intervention will be delivered to the clusters randomised to the intervention, after collection of baseline data (pre-intervention data) on 50 patients.

Trial Locations (19)

Unknown

Mount Vernon Cancer Centre, Northwood

Belfast City Hospital, Belfast

Queen Elizabeth Hospital, Birmingham

Addenbrookes Hospital, Cambridge

Velindre Hospital, Cardiff

The Western General Hospital, Edinburgh

Beaston Oncology Centre, Glasgow

Hull Royal Infirmary, Hull

St. James's Hospital, Leeds

Clatterbridge Centre for Oncology, Liverpool

The Royal Marsden Hospital, London

The Christie, Manchester

Freeman Hospital, Newcastle

City Hospital, Nottingham

Churchill Hospital, Oxford

Derriford Hospital, Plymouth

Southampton University Hospital, Southampton

The Royal Marsden Hospital, Sutton

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University of Edinburgh

OTHER